Remarks on the Prolactin Hypothesis of Peripartum Cardiomyopathy.
作者信息
Triebel Jakob, Clapp Carmen, Martínez de la Escalera Gonzalo, Bertsch Thomas
机构信息
Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg, Germany.
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Querétaro, México.
出版信息
Front Endocrinol (Lausanne). 2017 Apr 11;8:77. doi: 10.3389/fendo.2017.00077. eCollection 2017.
Abstract
摘要
相似文献
1
Remarks on the Prolactin Hypothesis of Peripartum Cardiomyopathy.关于围产期心肌病催乳素假说的评论
Front Endocrinol (Lausanne). 2017 Apr 11;8:77. doi: 10.3389/fendo.2017.00077. eCollection 2017.
2
From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.从实验室到临床：催乳素/血管抑制素轴的转化
Front Endocrinol (Lausanne). 2017 Dec 11;8:342. doi: 10.3389/fendo.2017.00342. eCollection 2017.
3
Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases.人类催乳素点突变及其对血管抑制素生成和血管抑制素相关疾病的预期影响。
Front Endocrinol (Lausanne). 2017 Nov 6;8:294. doi: 10.3389/fendo.2017.00294. eCollection 2017.
4
Prolactin-derived vasoinhibins increase anxiety- and depression-related behaviors.催乳素衍生的血管抑制素会增加焦虑和抑郁相关的行为。
Psychoneuroendocrinology. 2014 Jun;44:123-32. doi: 10.1016/j.psyneuen.2014.03.006. Epub 2014 Mar 21.
5
16 kDa vasoinhibin binds to integrin alpha5 beta1 on endothelial cells to induce apoptosis.16千道尔顿血管抑制素与内皮细胞上的整合素α5β1结合以诱导细胞凋亡。
Endocr Connect. 2018 May;7(5):630-636. doi: 10.1530/EC-18-0116. Epub 2018 Apr 5.
6
Principles of the prolactin/vasoinhibin axis.催乳素/血管抑制素轴的原理。
Am J Physiol Regul Integr Comp Physiol. 2015 Nov 15;309(10):R1193-203. doi: 10.1152/ajpregu.00256.2015. Epub 2015 Aug 26.
7
Vasoinhibin, an N-terminal Prolactin Fragment, Directly Inhibits Cardiac Angiogenesis in Three-dimensional Heart Culture.血管抑制素，一种N端催乳素片段，在三维心脏培养中直接抑制心脏血管生成。
Front Endocrinol (Lausanne). 2017 Jan 20;8:4. doi: 10.3389/fendo.2017.00004. eCollection 2017.
8
Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules.组织蛋白酶 D 是腺垂体血管抑制素生成的主要蛋白酶：裂解发生在泌乳素分泌颗粒内。
Endocrinology. 2009 Dec;150(12):5446-54. doi: 10.1210/en.2009-0390. Epub 2009 Oct 9.
9
Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy.糖尿病视网膜病变患者血清中催乳素相关血管抑制素的研究。
Eur J Endocrinol. 2009 Aug;161(2):345-53. doi: 10.1530/EJE-09-0130. Epub 2009 May 28.
10
Commentary: Prolactin Alters Blood Pressure by Modulating the Activity of Endothelial Nitric Oxide Synthase.评论：催乳素通过调节内皮型一氧化氮合酶的活性来改变血压。
Front Endocrinol (Lausanne). 2017 May 22;8:105. doi: 10.3389/fendo.2017.00105. eCollection 2017.
引用本文的文献
1
MicroRNA-146: Biomarker and Mediator of Cardiovascular Disease.微小RNA-146：心血管疾病的生物标志物与介质
Dis Markers. 2022 Oct 11;2022:7767598. doi: 10.1155/2022/7767598. eCollection 2022.
2
Immunometric and functional measurement of endogenous vasoinhibin in human sera.免疫计量法和功能性检测人血清中的内源性血管抑制素。
Front Endocrinol (Lausanne). 2024 Apr 29;15:1345996. doi: 10.3389/fendo.2024.1345996. eCollection 2024.
3
Endocrine causes of heart failure: A clinical primer for cardiologists.心力衰竭的内分泌病因：心内科医生的临床基础。
Indian Heart J. 2021 Jan-Feb;73(1):14-21. doi: 10.1016/j.ihj.2020.11.003. Epub 2020 Nov 11.
4
Peripartum Cardiomyopathy: a Review for the Clinician.围产期心肌病：临床医生综述
Curr Treat Options Cardiovasc Med. 2018 Sep 29;20(11):91. doi: 10.1007/s11936-018-0690-3.
5
From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.从实验室到临床：催乳素/血管抑制素轴的转化
Front Endocrinol (Lausanne). 2017 Dec 11;8:342. doi: 10.3389/fendo.2017.00342. eCollection 2017.
6
Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases.人类催乳素点突变及其对血管抑制素生成和血管抑制素相关疾病的预期影响。
Front Endocrinol (Lausanne). 2017 Nov 6;8:294. doi: 10.3389/fendo.2017.00294. eCollection 2017.
本文引用的文献
1
Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.使用多巴胺激动剂治疗围产期心肌病及随后妊娠并获得满意结局
Rev Bras Ginecol Obstet. 2016 Jun;38(6):308-13. doi: 10.1055/s-0036-1584567. Epub 2016 Jul 11.
2
Peripartum Cardiomyopathy.围生期心肌病。
Circulation. 2016 Apr 5;133(14):1397-409. doi: 10.1161/CIRCULATIONAHA.115.020491.
3
Principles of the prolactin/vasoinhibin axis.催乳素/血管抑制素轴的原理。
Am J Physiol Regul Integr Comp Physiol. 2015 Nov 15;309(10):R1193-203. doi: 10.1152/ajpregu.00256.2015. Epub 2015 Aug 26.
4
Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.一项评估溴隐亭对围产期心肌病女性左心室功能影响的随机对照多中心临床试验的原理与设计。
Clin Res Cardiol. 2015 Nov;104(11):911-7. doi: 10.1007/s00392-015-0869-5. Epub 2015 May 31.
5
New insights in prolactin: pathological implications.催乳素的新认识：病理意义。
Nat Rev Endocrinol. 2015 May;11(5):265-75. doi: 10.1038/nrendo.2015.36. Epub 2015 Mar 17.
6
On the Path toward Classifying Hormones of the Vasoinhibin-Family.迈向血管抑制素家族激素分类之路
Front Endocrinol (Lausanne). 2015 Feb 10;6:16. doi: 10.3389/fendo.2015.00016. eCollection 2015.
7
Molecular mechanisms of peripartum cardiomyopathy: A vascular/hormonal hypothesis.围产期心肌病的分子机制：一种血管/激素假说。
Trends Cardiovasc Med. 2015 Aug;25(6):499-504. doi: 10.1016/j.tcm.2015.01.004. Epub 2015 Jan 15.
8
Regulation of blood vessels by prolactin and vasoinhibins.催乳素和血管抑制素对血管的调节作用。
Adv Exp Med Biol. 2015;846:83-95. doi: 10.1007/978-3-319-12114-7_4.
9
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.PAI-1 介导 16K 泌乳素的抗血管生成和抗纤维蛋白溶解作用。
Nat Med. 2014 Jul;20(7):741-7. doi: 10.1038/nm.3552. Epub 2014 Jun 15.
10
Prolactin-derived vasoinhibins increase anxiety- and depression-related behaviors.催乳素衍生的血管抑制素会增加焦虑和抑郁相关的行为。
Psychoneuroendocrinology. 2014 Jun;44:123-32. doi: 10.1016/j.psyneuen.2014.03.006. Epub 2014 Mar 21.
Zotero 插件